“The pharmaceutical and healthcare industries are undergoing unprecedented change and specialized services such as those provided by Telerx will grow in importance as entities within these industries work to meet new regulations,” said Linda Schellenger, president of Telerx. “We are confident that our acquisition of Sentrx will position us for faster growth and enable us to better serve the needs of our clients.”
Michael O’Gorman, chief executive officer of Sentrx, said, “All of us at Sentrx are excited to be part of Telerx. By integrating our services and technologies with a company which has been successful in the healthcare space over the past 33 years, we will be able to more competitively offer the most comprehensive portfolio of services to a wide range of pharmaceutical companies and healthcare providers.”
Fairmount partners introduced the two companies and advised both of them under separate deal terms.